Skip to content
mapperlab
← Dashboard
Stock

RVTY

REVVITY, INC
Health CareHealth Care EquipmentLatest close $993 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
3
27 funds tracked
Ever held
8
Current + past
New this quarter
1
Exited this quarter
2

Marquee-fund ownership over time

Nov 12, 2015May 14, 2019Aug 14, 2024May 15, 2026
Now
3

This quarter's activity

New positions opened

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$49$99+102%
Citadel Advisors re-entered$117$99-15%
AQR Capital Management$117$99-15%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw 2× in & out→ $94-1%
Millennium Management→ $94-20%
Two Sigma Investments→ $95+6%
Maverick Capital→ $181-1%
Coatue Management→ $92-3%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at REVVITY, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
10
Filings · last 90d
20
Total on file
554
Recent SEC buffer
Most recent
May 11, 2026

30d / 90d windows measured from May 11, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 554 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · REVVITY, INC

Annual figures sourced directly from REVVITY, INC's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$2.86B
FY2025+4% YoY
Net income
$241.2M
FY2025-11% YoY
EPS (diluted)
$2.07
FY2025-6% YoY
Free cash flow(?)
$509.41M
FY2025-6% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for REVVITY, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Bridgewater AssociatesQ2 2026open$94$99+5%
D.E. ShawQ1 2026Q2 2026$95$94-1%
Citadel AdvisorsQ3 2025open$89$95+7%
Two Sigma InvestmentsQ3 2025Q1 2026$89$95+6%
Citadel AdvisorsQ1 2025Q2 2025$112$90-19%
Citadel AdvisorsQ3 2024Q4 2024$117$116-1%
D.E. ShawQ3 2024Q1 2025$117$112-4%
AQR Capital ManagementQ3 2024open$117$95-18%
Millennium ManagementQ3 2024Q2 2026$117$94-20%
Maverick CapitalQ3 2021Q4 2021$183$181-1%
Bridgewater AssociatesQ3 2021Q4 2024$181$119-34%
Bridgewater AssociatesQ2 2020Q3 2020$91$118+30%
Coatue ManagementQ1 2020Q2 2020$94$92-3%
Bridgewater AssociatesQ1 2019Q2 2019$92$88-5%
Bridgewater AssociatesQ2 2018Q4 2018$72$80+10%
Bridgewater AssociatesQ3 2016Q4 2016$53$49-7%
Bridgewater AssociatesQ4 2015Q1 2016$49$42-14%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.